VRNA
Verona Pharma
VRNA
VRNA
Delisted
VRNA was delisted on the 6th of October, 2025.
28 hedge funds and large institutions have $213M invested in Verona Pharma in 2020 Q3 according to their latest regulatory filings, with 15 funds opening new positions, 8 increasing their positions, 3 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
28
Holders Change
+10
Holders Change %
+55.56%
% of All Funds
0.57%
Holding in Top 10
4
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+100%
% of All Funds
0.08%
New
15
Increased
8
Reduced
3
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
RCM
RA Capital Management
Boston,
Massachusetts
|
+$31.8M |
| 2 |
O
OrbiMed
New York
|
+$27.7M |
| 3 |
NMC
NEA Management Company
Timonium,
Maryland
|
+$24.3M |
| 4 |
PA
Perceptive Advisors
New York
|
+$18M |
| 5 |
VC
Vivo Capital
Palo Alto,
California
|
+$9.71M |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
26
Morgan Stanley
New York
| $9K | +$9K | +1,500 | New |
|
|
CG
27
Cutler Group
San Francisco,
California
| $1K | +$1K | +200 | New |
|
28
Millennium Management
New York
| $68 | +$68 | +10,942 | New |
|
|
BBVA
29
Banco Bilbao Vizcaya Argentaria
Madrid,
Spain
| – | -$303K | -60,000 | Closed |
|
|
CCFM
30
Clear Creek Financial Management
Silverdale,
Washington
| – | -$175K | -37,500 | Closed |
|
31
Renaissance Technologies
New York
| – | -$100K | -21,410 | Closed |
|
|
TRCT
32
Tower Research Capital (TRC)
New York
| – | -$1K | -200 | Closed |
|
|
CFD
33
Creative Financial Designs
Kokomo,
Indiana
| – | -$1K | -200 | Closed |
|